Artificial Intelligence (AI) in Medical Diagnostics Market By Diseases (Oncology, Cardiovascular diseases, Neurological Disorders, Respiratory Diseases, Diabetes, and Infectious Diseases And By Application (Imaging Diagnostics, Genomic Diagnostics, Laboratory Diagnostics, Preventive Diagnostics, and Clinical Decision Support), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025–2035
Published Date: Sep 2024 | Report ID: MI1048 | 225 Pages
Report Coverage:
By Application
- Imaging Diagnostics
- Genomic Diagnostics
- Laboratory Diagnostics
- Preventive Diagnostics
- Clinical Decision Support
By Disease
- Oncology
- Cardiovascular diseases
- Neurological Disorders
- Respiratory Diseases
- Diabetes
- Infectious Diseases
- Others
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies
- NVIDIA Corporation
- Siemens Healthineers
- GE HealthCare
- Microsoft
- Intel Corporation
- IBM Watson Health
- Philips Healthcare
- Digital Diagnostics Inc.
- HeartFlow, Inc.
- Butterfly Network, Inc
- Zebra Medical Vision
- Aidence
- Enlitic, Inc.
- Icometrix
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.